PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy
Status:
Unknown status
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and safety of Jinyouli in preventing neutropenia in multiple
chemotherapy cycles in elderly patients with small cell lung cancer through a multicenter,
open, one-arm study Subjects with newly diagnosed small cell lung cancer who met the
inclusion/exclusion criteria, chemotherapy regimen: etoposide: 100 mg/m2, d1-3, carboplatin:
AUC=5, d1, q21d, prophylactic use test 48 h after chemotherapy Drug PEG-rhG-CSF.